fluorodeoxyglucose f18 has been researched along with 4-aminopyridine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartenstein, P; Bense, S; Best, C; Buchholz, HG; Dieterich, M; Schreckenberger, M; Wiener, V | 1 |
| Brandt, T; Jahn, K; Kremmyda, O; la Fougère, C; Strupp, M; Zwergal, A | 1 |
| Bartenstein, P; Beck, R; Böning, G; Brandt, T; Dieterich, M; Günther, L; Jahn, K; la Fougère, C; Potschka, H; Strupp, M; Xiong, G; Zwergal, A | 1 |
| de la Rosa, RF; Delgado, M; García-García, L; Pozo, MA; Shiha, AA | 1 |
4 other study(ies) available for fluorodeoxyglucose f18 and 4-aminopyridine
| Article | Year |
|---|---|
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.
Topics: 4-Aminopyridine; Aged; Cerebellum; Eye Movements; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Nystagmus, Pathologic; Positron-Emission Tomography; Potassium Channel Blockers | 2006 |
4-Aminopyridine suppresses positional nystagmus caused by cerebellar vermis lesion.
Topics: 4-Aminopyridine; Cerebellar Diseases; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Nystagmus, Pathologic; Positron-Emission Tomography; Potassium Channel Blockers | 2013 |
The mixed blessing of treating symptoms in acute vestibular failure--evidence from a 4-aminopyridine experiment.
Topics: 4-Aminopyridine; Animals; Brain; Disease Models, Animal; Drug Administration Schedule; Fluorodeoxyglucose F18; Male; Nystagmus, Pathologic; Positron-Emission Tomography; Postural Balance; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Sensation Disorders; Severity of Illness Index; Statistics as Topic; Time Factors; Vestibular Diseases; Vestibule, Labyrinth | 2014 |
Subacute Fluoxetine Reduces Signs of Hippocampal Damage Induced by a Single Convulsant Dose of 4-Aminopyridine in Rats.
Topics: 4-Aminopyridine; Animals; Brain Injuries; Caspase 9; Cell Death; Convulsants; Disease Models, Animal; Fluoresceins; Fluorodeoxyglucose F18; Fluoxetine; Glial Fibrillary Acidic Protein; Gliosis; Hippocampus; Male; Phosphopyruvate Hydratase; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Reaction Time; Selective Serotonin Reuptake Inhibitors | 2017 |